Literature DB >> 26335016

Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease.

F Valentino1, G Cosentino1, B Fierro1, S Realmuto1, S Mastrilli1, G Savettieri1, M D'Amelio2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26335016     DOI： 10.1007/s10072-015-2374-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  3 in total

1.  Rasagiline and Pisa syndrome in Parkinson's disease patients.

Authors:  Paolo Solla; Antonino Cannas; Gianni Orofino; Francesco Marrosu
Journal:  Neurol Sci       Date:  2014-12-07       Impact factor: 3.307

2.  Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease.

Authors:  F Valentino; G Cosentino; B Fierro; S Realmuto; S Mastrilli; G Savettieri; M D'Amelio
Journal:  Neurol Sci       Date:  2014-04-27       Impact factor: 3.307

Review 3.  Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.

Authors:  Orly Weinreb; Tamar Amit; Orit Bar-Am; Moussa B H Youdim
Journal:  Prog Neurobiol       Date:  2010-06-19       Impact factor: 11.685
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.